BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1220517)

  • 1. [Effect of dopamine on the portal pressure].
    Benko H; Peschl L; Schüller J; Neumayr A
    Acta Med Austriaca; 1975; 2(5):187-90. PubMed ID: 1220517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and experimental investigations of the effect of dopamine on haemodynamics and function of kidney and liver (author's transl)].
    Peschl L
    Wien Klin Wochenschr Suppl; 1978; 86():1-33. PubMed ID: 274863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of glucagon on portal hemodynamics in patients with liver cirrhosis].
    Cervinka J; Kaláb M; Jedlicka J; Petrtýl J; Marecek Z
    Cas Lek Cesk; 1991 Feb; 130(8):231-2. PubMed ID: 2025894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW; Kalk JF; Klein CP
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
    Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a serotonin S2 receptor antagonist on portal hypertension due to cirrhosis. Preliminary results of a heart and liver hemodynamic study].
    Deflandre J; Pirotte J; Etienne M; Carlier J
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):103-5. PubMed ID: 3400992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined liver vein and spleen pulp pressure measurements in patients with portal or splenic vein thrombosis.
    Keiding S; Solvig J; Grønbaek H; Vilstrup H
    Scand J Gastroenterol; 2004 Jun; 39(6):594-9. PubMed ID: 15223686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of phentolamine on portal pressure in cirrhotic patients with portal hypertension].
    Zhu J; Leng X; Yin J
    Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):92-4. PubMed ID: 10374485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
    Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
    Hepatology; 1991 Sep; 14(3):483-7. PubMed ID: 1874493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
    Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
    Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of cimetidine on wedged hepatic venous pressure in cirrhotic patients].
    Leng XS
    Zhonghua Wai Ke Za Zhi; 1991 Aug; 29(8):500-2, 525-6. PubMed ID: 1813246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver -- results of a pilot study.
    Deibert P; Schumacher YO; Ruecker G; Opitz OG; Blum HE; Rössle M; Kreisel W
    Aliment Pharmacol Ther; 2006 Jan; 23(1):121-8. PubMed ID: 16393289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal hypertension in lymphoproliferative and myeloproliferative disorders: hemodynamic and histological correlations.
    Dubois A; Dauzat M; Pignodel C; Pomier-Layrargues G; Marty-Double C; Lopez FM; Janbon C
    Hepatology; 1993 Feb; 17(2):246-50. PubMed ID: 8428721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver.
    Cervinka J; Kordac V; Kalab M
    J Int Med Res; 1989; 17(6):560-4. PubMed ID: 2628133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vasopressin on portal venous pressure.
    Kallio H; Lempinen M
    Acta Chir Scand; 1983; 149(1):49-52. PubMed ID: 6601347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of clinical findings in evaluating the degree of portal hypertension in patients with liver cirrhosis].
    Jedlicka J; Petrtýl J; Tesar V; Marecek Z; Cervinka J; Kordac V
    Cas Lek Cesk; 1989 Aug; 128(33):1035-9. PubMed ID: 2790908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension].
    Li S; Feng H; Zhu J; Zhong C; Leng X; Du R
    Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):287-90. PubMed ID: 12828169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Devascularization procedure and DSRS: a controlled randomized trial on selected haemodynamic portal flow pattern in schistosomal portal hypertension with variceal bleeding.
    Gawish Y; El-Hammadi HA; Kotb M; Awad AT; Anwar M
    Int Surg; 2000; 85(4):325-30. PubMed ID: 11589601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.